"We are very excited to be one of the first sites to participate in this study and one of only 3 sites currently enrolling patients in the New York tri-state region," said Dr. Jonathan Goldberg.
Westchester County, NY (PRWEB) June 24, 2014
The Cancer Treatment and Wellness Center at Northern Westchester Hospital is now enrolling patients for a clinical research study investigating the use of palbociclib (PD-0332991), a CDK 4/6 inhibitor being investigated for advanced stage breast cancer. CDK proteins can be involved in promoting the growth of cancer cells. Medications that block the activity of these proteins have shown promising activity in preliminary cancer clinical trials.
The Cancer Treatment and Wellness Center at Northern Westchester Hospital was one of the first sites in the world to have this Phase 3 study available to patients. This specific trial is evaluating the effectiveness of palbociclib when used in combination with fulvestrant in women with hormone receptor positive, Her-2 negative metastatic breast cancer that has progressed after prior endocrine therapy.
“We are very excited to be one of the first sites to participate in this study and one of only 3 sites currently enrolling patients in the New York tri-state region,” said Dr. Jonathan Goldberg, Medical Oncologist at Mount Kisco Medical Group and Medical Director of Cancer Clinical Trials at NWH. “Through the clinical trials program at NWH, we are able to provide patients with leading-edge care and access to investigational cancer drugs without having to travel outside of our community. Furthermore, we are now a destination for cancer patients from outside our community looking to gain access to these research studies."
For more information on this and other clinical trials, please contact the NWH Clinical Trials Program by visiting http://www.nwhc.net/clinicaltrials or by calling (914) 666.1366.
About the Mount Kisco Medical Group
The Mount Kisco Medical Group (MKMG) http://www.mkmg.com is a multi-specialty medical group that provides the highest quality medical care to over 300,000 patients in 28 different locations throughout Westchester, Putnam and Dutchess counties. Founded in 1946, MKMG has grown to over 280 physicians representing 40 different medical specialties with major campuses in Mount Kisco, Carmel, Katonah, Fishkill and Poughkeepsie. The Group is an independent clinical affiliate of the internationally recognized Massachusetts General Hospital. MKMG has on-site laboratory and radiology services, as well as endoscopy suites and infusion suites, rendering comprehensive care in one convenient location. The four basic principles of MKMG are to have the highest quality physicians, the highest quality diagnostic technology, state-of-the-art information technology, and superior patient satisfaction and service. The Group has always maintained a firm commitment to each of our patients... to provide high quality medical and surgical care in a warm, friendly setting, and in a caring manner. Each and every member of our professional and support staff is dedicated to this ideal: physicians, nurses, technicians and support personnel.
About Northern Westchester Hospital
Northern Westchester Hospital (NWH) provides quality, patient-centered care that is close to home through a unique combination of medical expertise, leading edge technology, and a commitment to humanity. Over 700 highly skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment.
NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. Our high quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For a complete list of our services, please visit http://www.nwhc.net.
Northern Westchester Hospital